Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy

Figure 1 Overall survival rate.

Figure 2 Comparison of survival rates between the two periods. The blue line represents patients diagnosed in the first period (2010-2014); the orange line represents patients diagnosed in the second period (2015-2019).

Figure 3 Comparison of survival rates Barcelona clinic liver cancer stages. The blue line represents patients with Barcelona Clinic Liver Cancer (BCLC) 0 or A (early); the orange line represents patients with BCLC B (intermediate); and the green line represents patients with BCLC C or D (advanced).

Figure 4 Comparison of survival rates between therapeutic groups. The blue line represents patients undergoing curative therapeutic treatment (surgical resection or percutaneous radiofrequency ablation); and the orange line represents patients undergoing non-curative therapeutic treatment (trans-arterial chemo embolization, selective internal radiation therapy, chemotherapy with sorafenib or palliation).